The U.S. pharmaceutical packaging services market is forecasted to expand from USD 3.29 billion in 2026 to USD 7.22 billion by 2035, growing at a CAGR of 9.1% from 2026 to 2035. Strict sterilization concern, rising outsourcing, and increasing biologics has fuelled the market to grow rapidly. Presence of small producers, rising focus towards child-resistant and tamper-evident packaging has fuelled the demand for development in this market.
U.S. pharmaceutical packaging services include focused, cGMP-compliant and FDA-regulated procedures for firmly enclosing, labelling, and distributing medicines. They confirm drug constancy, prevent pollution/fabricating, and preserve sterility from production over to the patient. These facilities encompass primary, secondary, and tertiary packaging, comprising specialized facilities such as cold chain logistics and serialisation. It is influenced by growing specialized drug demand, rising necessity for advanced drug transport, and the need for safe, compliant packaging options to shift products from manufacture to patients.
Technological transformation in the U.S. pharmaceutical packaging services market plays a significant role in integration of smart technology such as QR codes, RFID tags, and sensors. Rising patient-centric packaging production required development of user-friendly packaging with smart adherence-tracking process. Rapid shift recyclable and biodegradable packaging have enhanced the adoption of advanced technology such as AI to predict the recyclability potential of the material. These advancements raised the adoption of such packaging by appealing a wide range of consumers.
The major raw materials utilized in this market are aluminum, glass, paper, paperboard, and plastics such as (PE, PP, and PVC).
The component manufacturing in this market comprises plastic/glass vials, drug delivery devices, and prefillable syringes (PFS). Advancement of smart and secure packaging has raised the demand for this market.
This segment ensures specialized, safe, and cold-chain distribution heavily to expand the market.
The branded product segment dominated the market with highest share in 2025 due to huge growth in speciality pharmaceutical sector. The continuous growth in complex drug-device, biologics, and injectables has pushed this segment to expand. Presence of strict FDA guidelines related to product safety and traceability has raised the demand for such branded products. It is enhancing brand value, product safety, and stability. This market is growing rapidly due to increasing concern for hygienic and long-lasting packaging of pharma products.
The biosimilar packaging services segment is expected to grow at the fastest CAGR during the forecast period. This segment is growing due to enhanced focus for sustainable packaging. These are highly utilized for the packaging of sensitive, temperature-controlled, and sophisticated drugs packaging. Huge shift in the direction of eco-friendly, biodegradable, and recyclable packaging. These are cost-effective efficient solution for the packaging of sensitive drugs.
The primary packaging segment dominated the market with highest share in 2025 due to its drugs sterility, stability, and safety. It is majorly influenced by injectable therapies, and upsurge in biologics. Presence of strict regulatory guidelines for temperature-evident and child-resistance packaging has fuelled the demand for this market. Enhanced glass and specialized plastic packaging has raised the demand for this segment.
The secondary packaging segment is expected to grow at the fastest CAGR during the forecast period. This segment is growing due to high demand for smart and active packaging. Production of self-administered and high-value packaging demand to prevent counterfeiting has raised the demand for this segment. Constant growth in the direct-to-patient delivery facilities has fuelled the demand for this segment. There is a huge investment in the innovation of this segment which enhanced its adoption.
The small manufacturer size segment dominated the market with highest share in 2025 due to advanced outsourcing strategies to small producers and small pharmaceutical firms. These are the cost-effective solution with enhanced quality to build their image. High-quality packaging such as pouch, vial, and blister packaging has raised the demand for this segment. It is majorly influenced by specialized, efficient, and localized services. Growing demand for specialized and customized packaging has pushed this segment to grow efficiently.
The medium manufacturer size segment is expected to grow at the fastest CAGR during the forecast period. This segment is growing due to rapid response options, tailored and cost-effective packaging solutions. Huge investment in this segment has enhanced the production quality and process. It offers responsive services and flexibility which has enhanced the need for this segment. These companies are considered as bridge between high-volume and less-flexible producers for the production of specialized pouches.
Country Insights
The U.S. witnessing rapid growth in the market, due to massive demand for advanced packaging of drugs. Presence of strict FDA guidelines comprises child-resistance and serialization packaging. Incorporation of patient-centric, sustainable, and smart packaging technology has influenced the growth of this market. This market includes packaging of special and biologics drugs with enhanced manufacturing and distribution process. Presence of major market players such as Aphena Pharma Solutions, PCI Pharma Services, Legacy Pharma Solutions, All Packaging Services, LLC, and several others pushed advancement in this industry.
By Product
By Service Line
By Manufacturer Size
February 2026
February 2026
February 2026
February 2026
Download Sample
sales@towardspackaging.com
+1 804-441-9344
Schedule a Meeting